Mandate

Vinge has advised Medivir on directed new share issue

December 09, 2010

Medivir (NASDAQ OMX Stockholm) has carried out a directed new issue of shares for approximately SEK 280 million directed towards international institutional investors and qualified investors in Sweden. Vinge acted for Medivir.

Vinge’s team consisted of Erik Sjöman and Emil Hedberg.

Related

Vinge advises Main Capital and Björn Lundén in connection with the acquisition of Aprello

Vinge has advised Björn Lundén, a provider of accounting and financial administration software, in connection with the acquisition of Aprello AB (“Aprello”). The strategic acquisition complements Björn Lundén’s growth strategy in the European financial administration software market.
January 30, 2025

Vinge advises ABGSC in connection with EQL Pharma’s inaugural bond issuance

Vinge has advised ABG Sundal Collier in connection with EQL Pharma AB (publ)’s ( “EQL”) inaugural issuance of SEK 350,000,000 senior secured bonds within a framework of up to SEK 700,000.
January 24, 2025

Vinge advises the majority shareholders Altor, Telia Company, Time For Growth and Zenith VC in the divestment of shares in Marshall Group

Vinge advises the majority shareholders Altor, Telia Company, Time For Growth and Zenith VC in connection with the divestment of shares in Marshall Group AB (publ) (”Marshall Group”) to HongShan Group, formerly known as Sequoia China. The Marshall Family will continue as owner in the Marshall Group.
January 24, 2025